Baxter Meets Its Renewable Power Goal Early as Detailed in 2012 Sustainability Report

  Baxter Meets Its Renewable Power Goal Early as Detailed in 2012
  Sustainability Report

               Company Announces Recognition and Collaboration

Business Wire

DEERFIELD, Ill. -- July 8, 2013

Baxter International Inc. (NYSE: BAX) today issued its 14^th consecutive
Sustainability Report, available athttp://sustainability.baxter.com,
detailing the company’s commitment and progress to creating lasting social,
environmental and economic value by addressing the needs of stakeholders
worldwide.

Baxter employee Hannah Jeon and her daughters regularly volunteer at the Red
Cross Community Center ...

Baxter employee Hannah Jeon and her daughters regularly volunteer at the Red
Cross Community Center in Seoul, Korea, to bake loaves of bread for
underprivileged members of the community. (Photo: Business Wire)

''Sustainability encompasses virtually every aspect of how we do business,''
said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer.
''Just as Baxter’s mission is to save and sustain lives, we are committed to
helping our many global stakeholders thrive.''

Highlights from Baxter’s 2012 Sustainability Report include:

  *Exceeding Baxter’s goal of using 20 percent renewable power in its
    facilities by 2015. In 2012, 22 percent of Baxter's total energy use for
    operations was from renewable energy sources due in part to several
    on-site renewable energy projects. These included installation of a
    photovoltaic (PV) system at Baxter’s Toongabbie, Australia, facility that
    produces sufficient electricity for the office complex with the exception
    of the heating, ventilation and air conditioning (HVAC) system, and
    installation of a comprehensive geothermal cooling system at Baxter’s
    Orth, Austria, facility that uses the relatively constant temperature of
    the groundwater for cooling and heating the building, as opposed to
    traditional HVAC chiller systems. In late 2012, Baxter’s Malta facility
    began installation of the company’s largest on-site PV system that will
    provide approximately 23 percent of the site’s electricity and reduce the
    site’s greenhouse gas emissions (GHG) by 1,100 metric tons carbon dioxide
    equivalent annually.
  *Reducing GHG emissionsby 12 percent on an absolute basis since 2005, 39
    percent indexed to revenue, placing Baxter on track to exceed its 2015
    goal to reduce GHG from operations 45 percent indexed to revenue. This is
    due in part to adoption of innovative technologies such as Baxter’s Malta
    facility converting 95 percent of its lighting to high efficiency light
    emitting diode (LED) technology, and three facilities using boilers
    powered by sustainably sourced biomass fuels.
  *Creating a Human Rights Policy and updating its Ethics and Compliance
    Standards for Suppliers to encourage business partners to make similar
    efforts in the area of human rights. Baxter evaluates the sustainability
    performance of its suppliers, including related to human rights, via a
    survey to learn about each supplier’s sustainability programs and identify
    opportunities for best practice sharing and collaboration to improve the
    performance of both Baxter and its suppliers. Baxter routinely conducts
    quality audits of its suppliers and joined the Pharmaceutical Supply Chain
    Initiative in 2012, a group of pharmaceutical companies who share a vision
    of better social, economic and environmental outcomes for all those
    involved in the pharmaceutical supply chain.

Baxter's ninesustainability prioritiesreflect issues of key concern to
Baxter and its stakeholders in areas where the company is positioned to have a
positive impact. Priorities include strengthening access to healthcare,
enhancing math and science education, and a range of environmental initiatives
such as reducing energy use, waste generation, and water use.

Baxter's 2012 Sustainability Report is aligned with the Global Reporting
Initiative guidelines, which provide a uniform and transparent set of metrics
to systematically report on sustainability initiatives and results.

Baxter Earns Recognition for Sustainability Performance and Disclosure

Based on its sustainability performance, Baxter was included for the 12th year
in Corporate Responsibility magazine's 100 Best Corporate Citizens list. The
annual survey draws from firms in the Russell 1000 Index and is based on more
than 320 data points of publicly available information in seven categories:
environment, climate change, employee relations, human rights, governance,
finance and philanthropy.

Baxter placed second in the Environmental Tracking (ET) Scope 3 Disclosure
Leader Award rankings and ranked 13 and 35 in the ET North America 300 and ET
Global 800 Carbon Rankings, respectively, based on transparent, public
disclosure of greenhouse gas emissions that follow reporting guidelines and
are externally verified. These rankings are compiled by the Environmental
Investment Organisation, an independent not-for-profit research body promoting
carbon transparency and investment solutions designed to address climate
change.

Baxter Joins National Health Organization Supporting Environmental Practices

Baxter recently joined Practice Greenhealth, a membership organization that
provides a forum for collaboration with other healthcare companies and
organizations that are committed to improving their environmental performance
as well as that of the healthcare industry. Baxter’s membership is just one
way the company encourages improved environmental performance within the
company and across the industry.

Baxter has held environmental stewardship as a priority for more than three
decades, and has long set environmental goals for waste, energy, greenhouse
gas emissions, water and packaging as well as measuring progress and reporting
results. As part of its mission to save and sustain lives, Baxter is committed
to addressing environmental and social issues across the life cycle of its
products. These range from sustainable design and bioethics during research
and development, to energy and materials efficiency during manufacturing and
transport, to responsible advertising and promotion, and finally, product
repair, refurbishment and recycling for electronic products as appropriate at
end-of-life. Baxter also has programs to ensure high standards in quality,
safety and product integrity.

To further these efforts, Baxter launched a new Product Sustainability Program
in 2012, building on extensive collaboration among its research and
development, marketing and supply chain groups. The program team initiated new
projects to define life cycle environmental impacts for both individual
products and entire therapies. Additionally, Baxter’s product portfolio
includes two products that were the first medical products to receive Carbon
Footprint certification from the Carbon Trust, which provides independent
verification of the carbon footprints of products and services.

About Baxter

Baxter's commitment to sustainability spans more than three decades. The
company is included in the Dow Jones Sustainability Index and has been
recognized by Corporate Responsibility magazine as one of the 100 Best
Corporate Citizens and Newsweek’s Green Rankings as the leading U.S.
healthcare company. Baxter is a member of the Center for Health and the Global
Environment at Harvard Medical School, Center for Corporate Citizenship at
Boston College, and the Ethics & Compliance Officer Association. The company
endorses the Ceres principles and is an Organizational Stakeholder of the
Global Reporting Initiative. Further information about Baxter’s sustainability
activities can be found at www.sustainability.baxter.com.

Baxter International Inc., through its subsidiaries, develops, manufactures
and markets products that save and sustain the lives of people with
hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and
other chronic and acute medical conditions. As a global, diversified
healthcare company, Baxter applies a unique combination of expertise in
medical devices, pharmaceuticals and biotechnology to create products that
advance patient care worldwide.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130708005118/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50664490&lang=en

Contact:

Baxter International Inc.
Media Contact
Deborah Spak, (224) 948-2349
or
Investor Contacts
Mary Kay Ladone, (224) 948-3371
Clare Trachtman, (224) 948-3085